1-20 of 27
Authors: Peter Merkel
Journal Article
326. A RANDOMIZED PHASE 3 TRIAL EVALUATING THE SAFETY AND EFFICACY OF AVACOPAN IN PATIENTS WITH NEW OR RELAPSING ANCA-ASSOCIATED VASCULITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.050, https://doi.org/10.1093/rheumatology/kez063.050
Published: 29 March 2019
Journal Article
148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.025, https://doi.org/10.1093/rheumatology/kez059.025
Published: 29 March 2019
Journal Article
327. LONG-TERM SAFETY OF RITUXIMAB IN GRANULOMATOSIS WITH POLYANGIITIS OR MICROSCOPIC POLYANGIITIS: RESULTS OF THE FOUR-YEAR RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS REGISTRY Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.051, https://doi.org/10.1093/rheumatology/kez063.051
Published: 29 March 2019
Journal Article
043. SUBGLOTTIC STENOSIS AND ENDOBRONCHIAL DISEASE IN GRANULOMATOSIS WITH POLYANGIITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.042, https://doi.org/10.1093/rheumatology/kez057.042
Published: 29 March 2019
Journal Article
082. CLINICAL SUBSETS IN GIANT CELL ARTERITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.022, https://doi.org/10.1093/rheumatology/kez058.022
Published: 29 March 2019
Journal Article
232. CHANGE IN VASCULAR 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY ACTIVITY WITH TREATMENT IN LARGE VESSEL VASCULITIS IN RELATION TO CLINICAL AND SEROLOGIC ASSESSMENT Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez062.006, https://doi.org/10.1093/rheumatology/kez062.006
Published: 29 March 2019
Journal Article
126. DEVELOPMENT AND VALIDATION OF CASE-FINDING ALGORITHMS FOR THE IDENTIFICATION OF PATIENTS WITH GIANT CELL ARTERITIS AND TAKAYASU’S ARTERITIS IN LARGE HEALTHCARE ADMINISTRATIVE DATABASES Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.002, https://doi.org/10.1093/rheumatology/kez059.002
Published: 29 March 2019
Journal Article
077. CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.017, https://doi.org/10.1093/rheumatology/kez058.017
Published: 29 March 2019
Journal Article
222. PREFERENTIAL BINDING TO AN UNEXPECTED EPITOPE OF A CHIMERIC RECOMBINANT PROTEINASE 3 VARIANT BY ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez061.037, https://doi.org/10.1093/rheumatology/kez061.037
Published: 29 March 2019
Journal Article
330. TREATMENT RESPONSE CRITERIA FOR ANCA-ASSOCIATED VASCULITIS: RESULTS OF A SCOPING REVIEW Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.054, https://doi.org/10.1093/rheumatology/kez063.054
Published: 29 March 2019
Journal Article
045. EVALUATION OF NOVEL SERUM BIOMARKERS OF DISEASE ACTIVITY IN GIANT CELL ARTERITIS, TAKAYASU’S ARTERITIS, POLYARTERITIS NODOSA, AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.044, https://doi.org/10.1093/rheumatology/kez057.044
Published: 29 March 2019
Journal Article
190. DETECTION OF CIRCULATING PR3-SPECIFIC B CELLS IN PATIENTS WITH ACTIVE ANCA-ASSOCIATED VASCULITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez061.004, https://doi.org/10.1093/rheumatology/kez061.004
Published: 29 March 2019
Journal Article
083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.023, https://doi.org/10.1093/rheumatology/kez058.023
Published: 29 March 2019
Journal Article
266. OUTCOME MEASURES IN LARGE-VESSEL VASCULITIS: RELATIONSHIPS BETWEEN PATIENT, PHYSICIAN, IMAGING, AND LABORATORY-BASED DOMAINS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez062.040, https://doi.org/10.1093/rheumatology/kez062.040
Published: 29 March 2019
Journal Article
160. VERITAS: VASCULITIS: EFFECTS OF REMISSION MAINTENANCE THERAPIES ON RELAPSE AND SIDE EFFECTS ON PATIENT PREFERENCES: A STUDY PROTOCOL Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.037, https://doi.org/10.1093/rheumatology/kez059.037
Published: 29 March 2019
Journal Article
020. IDENTIFICATION OF TARGET ANTIGENS FOR ANTI-ENDOTHELIAL CELL ANTIBODIES IN PATIENTS WITH TAKAYASU’S ARTERITIS USING PROTEOMICS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.019, https://doi.org/10.1093/rheumatology/kez057.019
Published: 29 March 2019
Journal Article
140. THE VASCULITIS PREGNANCY REGISTRY (VPREG): BASELINE INFORMATION FOR THE FIRST 3 YEARS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.017, https://doi.org/10.1093/rheumatology/kez059.017
Published: 29 March 2019
Journal Article
138. DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.015, https://doi.org/10.1093/rheumatology/kez059.015
Published: 29 March 2019
Journal Article
180. LONGITUDINAL CHANGES IN THE NASAL MICROBIOME OF PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez060.007, https://doi.org/10.1093/rheumatology/kez060.007
Published: 29 March 2019
Journal Article
361. THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS Free
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez063.085, https://doi.org/10.1093/rheumatology/kez063.085
Published: 29 March 2019
